Wall Street Zen lowered shares of Aurora Cannabis (NASDAQ:ACB - Free Report) from a hold rating to a sell rating in a research note released on Friday morning.
Aurora Cannabis Stock Down 0.4%
Shares of ACB traded down $0.02 during trading hours on Friday, reaching $4.53. The stock had a trading volume of 495,179 shares, compared to its average volume of 1,541,808. Aurora Cannabis has a 12 month low of $3.42 and a 12 month high of $7.20. The firm has a 50-day simple moving average of $4.99 and a 200 day simple moving average of $4.75. The company has a current ratio of 4.31, a quick ratio of 2.16 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $254.63 million, a price-to-earnings ratio of 41.18 and a beta of 1.75.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last posted its quarterly earnings results on Wednesday, June 18th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.04). Aurora Cannabis had a return on equity of 0.13% and a net margin of 1.32%. The firm had revenue of $63.34 million for the quarter, compared to the consensus estimate of $88.85 million. Equities research analysts predict that Aurora Cannabis will post 0.46 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Aurora Cannabis
Several hedge funds have recently added to or reduced their stakes in ACB. Goldman Sachs Group Inc. raised its position in Aurora Cannabis by 4.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 743,903 shares of the company's stock worth $3,266,000 after buying an additional 29,099 shares during the last quarter. Renaissance Technologies LLC raised its position in Aurora Cannabis by 8.6% in the 4th quarter. Renaissance Technologies LLC now owns 714,655 shares of the company's stock worth $3,037,000 after buying an additional 56,400 shares during the last quarter. Cubist Systematic Strategies LLC raised its position in Aurora Cannabis by 358.6% in the 1st quarter. Cubist Systematic Strategies LLC now owns 238,460 shares of the company's stock worth $1,047,000 after buying an additional 186,462 shares during the last quarter. Northwest & Ethical Investments L.P. purchased a new position in Aurora Cannabis in the 1st quarter worth about $452,000. Finally, Dimensional Fund Advisors LP raised its position in Aurora Cannabis by 7.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 84,921 shares of the company's stock worth $361,000 after buying an additional 5,800 shares during the last quarter. 47.63% of the stock is owned by institutional investors.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
